Procter & Gamble Health share price

Balanced risk
  • 30%Low risk
  • 30%Moderate risk
  • 30%Balanced risk
  • 30%High risk
  • 30%Extreme risk
  • ₹5,090.00(-2.60%)
    April 25, 2025 15:29:10 PM IST
    • NSE
    • BSE
  • Vol : 14.51K (NSE + BSE)
    Last 20 day avg : 10.37 K

Procter & Gamble Health is trading -2.60% lower at Rs 5,090.00 as compared to its last closing price. Procter & Gamble Health has been trading in the price range of 5,239.95 & 5,047.75. Procter & Gamble Health has given -0.32% in this year & 0.42% in the last 5 days. Procter & Gamble Health has TTM P/E ratio 36.77 as compared to the sector P/E of 30.66.The company posted a net profit of 90.90 Crores in its last quarter.Listed peers of Procter & Gamble Health include Granules India (-4.99%), Marksans Pharma (-5.34%), Procter & Gamble Health (-2.60%).The Mutual Fund holding in Procter & Gamble Health was at 10.54% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Procter & Gamble Health was at 6.86% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 25, 2025, 09:50 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    2.68
    Higher than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    16.10
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    36.65
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.55
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
5,047.75
Highest
5,239.95
52 week range
Lowest
4,640.30
Highest
5,835.95
Procter & Gamble Health News
Procter & Gamble Health Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue fell during September quarter by 0.06% from Rs 309.97 crore to Rs 309.77 crore, year-on-year
    • financial-insightsThe company has grown its September quarter profit by 26.13% from Rs 72.07 crore to Rs 90.90 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Procter & Gamble Health Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 5,328.95
  • R2
  • 5,515.60
  • R3
  • 5,697.40
Pivot5,147.15
  • S1
  • 4,960.50
  • S2
  • 4,778.70
  • S3
  • 4,592.05
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Procter & Gamble Health Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Granules India
Bearish
452.00-4.9910,967.8328.873.640.314.72
Marksans Pharma
Neutral
216.10-5.349,788.3429.854.710.289.20
Procter & Gamble Health
Bearish
5,090.00-2.608,422.9439.9316.162.671.28
Fdc
Neutral
423.80-0.646,920.2423.743.39-0.60
Aarti Pharmalabs
Bullish
734.45-2.636,661.1930.803.8-0.95
Procter & Gamble Health Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Procter & Gamble Health is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 51.82%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.15 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.10 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    UTI MNC Fund Regular Plan Growth
    NA
    • Amount Invested (Cr.) 123.98
    • % of AUM 4.70
    UTI Healthcare Fund Regular Plan Growth
    NA
    • Amount Invested (Cr.) 38.09
    • % of AUM 3.65
    Sundaram Long Term Tax Advantage Fund Series IV Regular Growth
    NA
    • Amount Invested (Cr.) 0.64
    • % of AUM 3.24
    Sundaram Long Term Tax Advantage Fund Series III Regular Growth
    NA
    • Amount Invested (Cr.) 0.90
    • % of AUM 2.99
    Sundaram Long Term Micro Cap Tax Advantage Fund Series V Regular Growth
    NA
    • Amount Invested (Cr.) 0.81
    • % of AUM 2.98
    Procter & Gamble Health Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-29Audited Results & Final Dividend
    2025-02-12Quarterly Results & Interim Dividend
    2024-11-04Quarterly Results
    2024-08-21Audited Results & Final Dividend
    2024-05-02Quarterly Results
    About the company Procter & Gamble Health
    • IndustryBiotechnology & Drugs
    • ISININE199A01012
    • BSE Code500126
    • NSE CodePGHL
    Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
    • Management Info
    • Lokesh ChandakChief Financial Officer, Executive Director
    • Zeal RupaniCompliance Officer, Company Secretary
    • Milind ThatteManaging Director, Executive Director
    Procter & Gamble Health Share Price FAQs

    Procter & Gamble Health is trading at 5090.00 as on Fri Apr 25 2025 09:59:10. This is -2.60% lower as compared to its previous closing price of 5225.75.

    The market capitalization of Procter & Gamble Health is 8422.94 Cr as on Fri Apr 25 2025 09:59:10.

    The 52 wk high for Procter & Gamble Health is 5835.95 whereas the 52 wk low is 4640.30

    Procter & Gamble Health can be analyzed on the following key metrics -

    • TTM P/E: 36.77
    • Sector P/E: 30.66
    • Dividend Yield: 2.68%
    • D/E ratio: 0.01

    Procter & Gamble Health reported a net profit of 200.98 Cr in 2024.

    The Mutual Fund Shareholding was 10.54% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Procter & Gamble Health QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Procter & Gamble Health share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.